Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04322955
Title CYTO Reductive Surgery in Kidney Cancer Plus Immunotherapy and Targeted Kinase Inhibition (Cyto-KIK)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Mark Stein

renal cell carcinoma


Cabozantinib + Nivolumab

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.